Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 127.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 66,633
  • Market Cap: £133.06m
  • RiskGrade: 114

Latest ShareCast News

Cello Health buys US-based scientific consulting firm ISS

By Michele Maatouk

Date: Friday 16 Aug 2019

(Sharecast News) - Healthcare-led advisory group Cello Health has announced the acquisition of Innovative Science Solutions (ISS), a US-based scientific consulting firm, for up to $10.5m.

Cello Health reports solid growth in 'strong' first half

By Iain Gilbert

Date: Thursday 18 Jul 2019

(Sharecast News) - Advisory group Cello Health anticipates that full-year earnings will "at least be in line with current expectations" after recording growth across the whole business.

Cello Health revenues and headline profits grow in Q1

By Iain Gilbert

Date: Wednesday 08 May 2019

(Sharecast News) - Healthcare-focused advisory group Cello Health saw like-for-like net revenue and headline pre-tax profits grow in the first quarter of its trading year, something it expects to carry over into the second quarter.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 127.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 139.50
52 Week Low 96.00
Volume 66,633
Shares Issued 104.77m
Market Cap £133.06m
RiskGrade 114

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
75.83% below the market average75.83% below the market average75.83% below the market average75.83% below the market average75.83% below the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average
Price Trend
57.79% above the market average57.79% above the market average57.79% above the market average57.79% above the market average57.79% above the market average
65.00% above the sector average65.00% above the sector average65.00% above the sector average65.00% above the sector average65.00% above the sector average
Income
0.68% above the market average0.68% above the market average0.68% above the market average0.68% above the market average0.68% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
31.98% below the market average31.98% below the market average31.98% below the market average31.98% below the market average31.98% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 23-Aug-2019

Time Volume / Share Price
13:53 7,000 @ 127.25p
10:19 50,000 @ 127.75p
10:28 50,000 @ 127.75p
10:18 9,633 @ 129.00p
09:02 35,500 @ 128.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page